Publications by the researcher in collaboration with Belén Gago Calderón (19)

2023

  1. Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit

    Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 4949-4963

2022

  1. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism

    Neurobiology of Disease, Vol. 167

  2. Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism

    Brain, Vol. 145, Núm. 6, pp. 2092-2107

2020

  1. Correction to: Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats (Psychopharmacology, (2020), 237, 8, (2419-2431), 10.1007/s00213-020-05544-6)

    Psychopharmacology

  2. Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats

    Psychopharmacology, Vol. 237, Núm. 8, pp. 2419-2431

  3. [18F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 11, pp. 2602-2612

2019

  1. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disorders

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 46, Núm. 10, pp. 2065-2076

  2. Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease

    Neurobiology of Aging, Vol. 75, pp. 126-135

2018

  1. Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia

    Brain Pathology, Vol. 28, Núm. 1, pp. 43-57

  2. Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study

    Movement Disorders, Vol. 33, Núm. 11, pp. 1809-1813

  3. Transcriptomic integration of D4R and MOR signaling in the rat caudate putamen

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study

    Movement Disorders, Vol. 32, Núm. 7, pp. 1066-1073

2016

  1. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

    Movement Disorders, Vol. 31, Núm. 6, pp. 861-881

2015

  1. Cambios en la sustancia gris en pacientes con enfermedad de parkinson y bloqueos de la marcha

    Revista de Neurologia

  2. Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches

    Neuroscience and Biobehavioral Reviews, Vol. 56, pp. 294-314

  3. Parkinsonism, cognitive deficit and behavioural disturbance caused by a novel mutation in the polymerase gamma gene

    Journal of the Neurological Sciences, Vol. 350, Núm. 1-2, pp. 93-97

  4. The Relationship Between Atrophy and Hypometabolism: Is It Regionally Dependent in Dementias?

    Current Neurology and Neuroscience Reports, Vol. 15, Núm. 7

2014

  1. Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2

    Movement Disorders, Vol. 29, Núm. 6, pp. 750-755

2013

  1. l-dopa-induced dyskinesias in unilateral 6-hydroxydopamine-lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra pars reticulata

    Synapse, Vol. 67, Núm. 7, pp. 407-414